Lumakras

E2041328 UNEXPLORED

Lumakras is a targeted cancer therapy developed by Amgen that inhibits the KRAS G12C mutation, primarily used to treat certain types of non-small cell lung cancer.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
Lumakras canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Amgen → product → Lumakras ⓘ